← All trials
NCT04931628
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2023
- First posted
- Jun 18, 2021
- Last posted
- Jun 18, 2021
- Enrollment
- 190
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zhejiang UniversityLead sponsor
- Zhejiang Chinese Medical UniversityCollaborator
- Zhejiang UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
- Zhejiang UniversityCollaborator
- Zhejiang UniversityCollaborator
- Red Cross Hospital, Hangzhou, ChinaCollaborator
- Ningbo No. 1 HospitalCollaborator
- Wenzhou Medical UniversityCollaborator
- Xiaoshan People's HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.